tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Navin Jacob, 20 are a HOLD (37.04%), 32 are a BUY (59.26%), 2 are a SELL (3.7%).
Analyst Navin Jacob, carries an average stock price target met ratio of 71.76% that have a potential upside of 24.37% achieved within 561 days. Previously, Navin Jacob worked at UBS, DEUTSCHE BANK.
Navin Jacob’s has documented 112 price targets and ratings displayed on 19 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on RAPT, RAPT Therapeutics at 28-Mar-2022.
Analyst best performing recommendations are on MDGL (MADRIGAL PHARMACEUTICALS).
The best stock recommendation documented was for MDGL (MADRIGAL PHARMACEUTICALS) at 1/23/2019. The price target of $119 was fulfilled within 14 days with a profit of $10.04 (9.21%) receiving and performance score of 6.58.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 12-Sep-2025
$303
$46.54 (18.15%)
$298
20 days ago
(20-Aug-2026)
2/8 (25%)
$41.17 (15.72%)
35
0.94
Buy Since 08-Dec-2021
$300
$43.54 (16.98%)
$295
23 days ago
(17-Aug-2026)
9/11 (81.82%)
$49.67 (19.84%)
469
0.57
Buy Since 23-Jan-2023
$260
$3.54 (1.38%)
$235
30 days ago
(10-Aug-2026)
9/9 (100%)
$12.03 (4.85%)
127
2.22
Buy Since 06-Feb-2020
$288
$31.54 (12.30%)
$261
1 months 5 days ago
(04-Aug-2026)
36/37 (97.3%)
$44.2 (18.13%)
434
1.18
Buy Since 23-Jan-2024
$285
$28.54 (11.13%)
$265
1 months 6 days ago
(03-Aug-2026)
25/26 (96.15%)
$39.9 (16.28%)
233
1.21
